A team of researchers has spent years working to develop an effective treatment for stroke that focuses on the use of a peptidase known as neurolysin. The team is now evaluating the potential of neurolysin as a therapeutic target for stroke by seeking to identify small molecules capable of enhancing its activity and catalytic efficiency.
